# The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-hdac-inhibitor-quisinostat-jnj-26481585-supresses-hepatocellular-carcinoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bin He,Longfei Dai,Xiaoqian Zhang,Diyu Chen,Jingbang Wu,Xiaode Feng,Yanpeng Zhang,Haiyang Xie,Lin Zhou,Jian Wu,Shusen Zheng |
| Citations | 47 |
| DOI | 10.7150/ijbs.27661 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | http://www.ijbs.com/v14p1845.pdf |
| OpenAlex ID | https://openalex.org/W2898344576 |
| PMID | 30443188 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Longfei Dai](https://scholariq.org/researchers/longfei-dai/)

## Paper primary topic

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)

## Paper topics

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.